Ceramides Mediate Insulin-Induced Impairments in Cerebral Mitochondrial Bioenergetics in ApoE4 Mice
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242316635 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sheryl T Carr und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USA. Hauptthemen laut MEDLINE: Insulin Resistance, Neurodegenerative Diseases, Hyperinsulinism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brigham Young University.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most common form of neurodegenerative disease worldwide. A large body of work implicates insulin resistance in the development and progression of AD. Moreover, impairment in mitochondrial function, a common symptom of insulin resistance, now represents a fundamental aspect of AD pathobiology. Ceramides are a class of bioactive sphingolipids that have been hypothesized to drive insulin resistance. Here, we describe preliminary work that tests the hypothesis that hyperinsulinemia pathologically alters cerebral mitochondrial function in AD mice via accrual of the ceramides. Homozygous male and female ApoE4 mice, an oft-used model of AD research, were given chronic injections of PBS (control), insulin, myriocin (an inhibitor of ceramide biosynthesis), or insulin and myriocin over four weeks. Cerebral ceramide content was assessed using liquid chromatography–mass spectrometry. Mitochondrial oxygen consumption rates were measured with high-resolution respirometry, and H2O2 emissions were quantified via biochemical assays on brain tissue from the cerebral cortex. Significant increases in brain ceramides and impairments in brain oxygen consumption were observed in the insulin-treated group. These hyperinsulinemia-induced impairments in mitochondrial function were reversed with the administration of myriocin. Altogether, these data demonstrate a causative role for insulin in promoting brain ceramide accrual and subsequent mitochondrial impairments that may be involved in AD expression and progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USA.
ORCID-Profile: Cameron M Hanegan
Förderung
- Brigham Young University
Zitieren
APA
Carr, S. T., Saito, E. R., Walton, C. M., Saito, J. Y., Hanegan, C. M., Warren, C. E., Trumbull, A. M., & Bikman, B. T. (2023). Ceramides Mediate Insulin-Induced Impairments in Cerebral Mitochondrial Bioenergetics in ApoE4 Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242316635
Vancouver
Carr ST, Saito ER, Walton CM, Saito JY, Hanegan CM, Warren CE, et al. Ceramides Mediate Insulin-Induced Impairments in Cerebral Mitochondrial Bioenergetics in ApoE4 Mice. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242316635
BibTeX
@article{Carr2023,
author = {Carr, Sheryl T and Saito, Erin R and Walton, Chase M and Saito, Jeremy Y and Hanegan, Cameron M and Warren, Cali E and Trumbull, Annie M and Bikman, Benjamin T},
title = {Ceramides Mediate Insulin-Induced Impairments in Cerebral Mitochondrial Bioenergetics in ApoE4 Mice},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242316635}
}
EUVIMED